PAK3 pathogenic variant associated with sleep-related hypermotor epilepsy in a family with parental mosaicism
Antonio Gambardella1, Yu-Chi Liu2,3,4, Mark F Bennett2,3,4
1Institute of Neurology, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.
Abstract:
Protein-activated kinases mediate spine morphogenesis and synaptic plasticity. PAK3 is part of the p21-activated kinases (PAKs) family of Ras-signaling serine/threonine kinases. Pathogenic variants in the X-linked gene PAK3 have been described in patients with neurodevelopmental syndromes. We analyzed an Italian family with sleep-related hypermotor epilepsy, intellectual disability, psychiatric and behavioral problems, and dysmorphic facial features. A novel PAK3 c.342_344del (p.Lys114del) inframe deletion was detected in the family. Protein structure analysis supported deleterious impact of p.Lys114 deletion through loss or partial loss of autoinhibition of PAK3 protein kinase activity. The male proband had drug-resistant hypermotor seizures and moderate intellectual disability. His brother had drug-responsive hypermotor seizures and mild intellectual disability. Both brothers were hemizygous and had psychiatric and behavioral problems as well as dysmorphic facial features. Their mother had never had seizures but was shown to be mosaic for the PAK3 pathogenic variant. She had normal intellect but did have short stature and dysmorphic facial features similar to her sons. This is the first reported association of a PAK3 pathogenic variant with sleep-related hypermotor epilepsy. PAK3 testing should be considered in families with suspected X-linked sleep-related hypermotor epilepsy and intellectual disability, including for mosaicism in mildly affected females. PLAIN LANGUAGE SUMMARY: We studied an Italian family with sleep-related hypermotor epilepsy, intellectual disability, psychiatric and behavioral problems, and dysmorphic facial features. A novel PAK3 c.342_344del (p.Lys114del) inframe deletion was detected in the family. Protein structure analysis supported deleterious impact of p.Lys114 deletion through loss or partial loss of autoinhibition of PAK3 protein kinase activity. This is the first reported association of a PAK3 pathogenic variant with sleep-related hypermotor epilepsy. PAK3 testing should be considered in families with suspected X-linked sleep-related hypermotor epilepsy and intellectual disability, including for mosaicism in mildly affected females.
Insights
A novel deletion in the PAK3 gene is linked to X-linked sleep-related hypermotor epilepsy and intellectual disability. This finding suggests PAK3 gene testing for related neurodevelopmental disorders, including mosaicism in females.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- Protein-activated kinases (PAKs) are crucial for neuronal development and function.
- Pathogenic variants in the X-linked PAK3 gene are associated with neurodevelopmental disorders.
- Sleep-related hypermotor epilepsy (SRE) is a complex epilepsy syndrome often with genetic underpinnings.
Purpose of the Study:
- To investigate the genetic basis of a novel neurodevelopmental syndrome in an Italian family.
- To identify the specific genetic variant responsible for the observed phenotype, including SRE, intellectual disability, and behavioral issues.
- To explore the functional impact of the identified variant on PAK3 protein activity.
Main Methods:
- Family-based genetic analysis to identify pathogenic variants.
- Next-generation sequencing to detect mutations in the PAK3 gene.
- Protein structure analysis to predict the functional consequences of the identified variant.
Main Results:
- A novel inframe deletion, c.342_344del (p.Lys114del), in the PAK3 gene was identified in the affected family members.
- The p.Lys114del variant is predicted to cause loss or partial loss of PAK3 autoinhibition, impacting kinase activity.
- The study reports the first association between a PAK3 pathogenic variant and sleep-related hypermotor epilepsy.
Conclusions:
- The identified PAK3 pathogenic variant is strongly associated with a phenotype including SRE, intellectual disability, and behavioral problems.
- PAK3 gene testing should be considered in the diagnostic workup of X-linked SRE and intellectual disability.
- The study highlights the importance of considering X-linked inheritance and potential mosaicism in affected families.
Related Concept Videos
Genetic Lingo
Pleiotropy
Sex-linked Disorders
Incomplete Dominance
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Parkinson Disease l: Introduction


